Northern Trust
AKCA

Northern Trust’s Akcea Therapeutics Inc AKCA Stock Holding History

Northern Trust’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-253,393
Closed -$4.6M – 4467
2020
Q3 		$4.6M Sell
253,393
-9,661
-4% -$137K ﹤0.01% 2586
2020
Q2 		$3.6M Buy
263,054
+66,812
+34% +$1.03M ﹤0.01% 2717
2020
Q1 		$2.81M Buy
196,242
+2,556
+1% +$42K ﹤0.01% 2655
2019
Q4 		$3.28M Sell
193,686
-2,001
-1% -$37.2K ﹤0.01% 2834
2019
Q3 		$3.01M Sell
195,687
-2,488
-1% -$53K ﹤0.01% 2857
2019
Q2 		$4.65M Buy
198,175
+1,390
+0.7% +$34.3K ﹤0.01% 2602
2019
Q1 		$5.58M Buy
196,785
+6,766
+4% +$197K ﹤0.01% 2500
2018
Q4 		$5.73M Sell
190,019
-2,137
-1% -$59.9K ﹤0.01% 2418
2018
Q3 		$6.73M Buy
192,156
+8,085
+4% +$245K ﹤0.01% 2509
2018
Q2 		$4.36M Buy
184,071
+13,147
+8% +$314K ﹤0.01% 2753
2018
Q1 		$4.38M Buy
170,924
+2,687
+2% +$57.8K ﹤0.01% 2665
2017
Q4 		$2.92M Buy
168,237
+5,056
+3% +$99.1K ﹤0.01% 2909
2017
Q3 		$4.51M Buy
+163,181
New +$3.02M ﹤0.01% 2693

Northern Trust's AKCA Position: Q4 2020 in Review

Northern Trust sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 253,393 shares — an estimated $4.6M sold.

Northern Trust first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $6.73M in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Northern Trust reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Northern Trust sold 253,393 Akcea Therapeutics Inc shares in Q4 2020, an estimated $4.6M.
  • Northern Trust first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Northern Trust's Akcea Therapeutics Inc position peaked at $6.73M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.